Premium

Alternative Insight and Premium Journalism

Latest Articles

David Einhorn (Scott Eells/Bloomberg)

November Surge Moves Greenlight Close to Breaking Even

Stephen Taub December 1, 2020

Larry Robbins (Michael Nagle/Bloomberg)

Larry Robbins’ SPAC Is Crushing It, While His Hedge Fund Is Staging a Rebound

Stephen Taub November 30, 2020

Stanley Druckenmiller (Michael Nagle/Bloomberg)

Stan Druckenmiller Just Got (Even More) Bullish

Stephen Taub November 25, 2020

Michael Nagle/Bloomberg

Has Shareholder Activism Caught the Virus?

Michelle Celarier November 24, 2020

Matthew Staver/Bloomberg

Tiger Global, Viking, Maverick Eye IPOs

Stephen Taub November 24, 2020

Jason Karp (Misha Friedman/Bloomberg)

Jason Karp’s Next Act? A SPAC.

Stephen Taub November 23, 2020

Amish Mehta (Peter Foley/Bloomberg)

How SQN Successfully Played Covid

Stephen Taub November 20, 2020

Bill Ackman (Andrew Harrer/Bloomberg)

Ackman Hires First Woman for Investment Team

Michelle Celarier November 19, 2020

(Angus Mordant/Bloomberg)

These Hedge Funds Made Savvy Post-Covid Bets

Stephen Taub November 19, 2020

Josh Resnick (Kholood Eid/Bloomberg)

Jericho’s Aggressive Trading Pays Off

Stephen Taub November 18, 2020

Barry Rosenstein (Andrew Harrer/Bloomberg)

This Company Is Jana’s Next Activist Target

Stephen Taub November 18, 2020

(Jeenah Moon/Bloomberg)

The Tiger Crowd’s Fresh Buys

Stephen Taub November 17, 2020

(Michael Nagle/Bloomberg)

Trian Dumped GE Stock, but Druckenmiller Stood Pat in Q3 as SEC Probe Heated Up

Michelle Celarier November 17, 2020

(Michael Nagle/Bloomberg)

Soros, Starboard, Rokos Make Big ETF Bets

Stephen Taub November 16, 2020

Robert Shafir, CEO of Sculptor. (Andrew Harrer/Bloomberg)

Life After a Bribery Scandal

Stephen Taub November 13, 2020

Oleg Nodelman (Amanda Gordon/Bloomberg)

Where EcoR1 Stands to Profit From Healthy Deal Making

Stephen Taub November 13, 2020

Carson Block (Anthony Kwan/Bloomberg)

Muddy Waters Takes Aim at MultiPlan

Michelle Celarier November 11, 2020

(Alex Kraus/Bloomberg)

How a Biden Presidency — And a Covid Vaccine — Could Shift Hedge Fund Fortunes

Michelle Celarier November 10, 2020

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

develop build:2025-12-18 Login